{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:15:13Z","timestamp":1789978513862,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cardiogenic shock refractory to standard therapy with inotropes and\/or intra-aortic balloon pump is accompanied with an unacceptable high mortality. Percutaneous left ventricular assist devices may provide a survival benefit for these very sick patients. In this study, we describe our experience with the Impella 5.0 device used in the setting of refractory cardiogenic shock.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this observational, retrospective, single-center study we included all the consecutive patients supported with Impella 5.0, between May 2008 and December 2013, for refractory cardiogenic shock. Patients\u2019 baseline and procedural characteristics, hemodynamics and outcome to the first 48\u00a0h of support, to ICU discharge and day-28 visit were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 40 patients were included in the study. Median age was 57\u00a0years and 87.5\u00a0% were male. Cardiogenic shock resulted from acute myocardial infarction in 17 patients (43\u00a0%), dilated cardiomyopathy in 12 (30\u00a0%) and postcardiotomy cardiac failure in 7 (18\u00a0%). In 15 patients Impella 5.0 was added to an ECMO to unload the left ventricle. The median SOFA score for the entire cohort prior to circulatory support was 12 [10\u201314] and the duration of Impella support was 7 [5\u201310] days. We observed a significant decrease of the inotrope score (10 [1\u201317] vs. 1 [0\u20139];<jats:italic>p<\/jats:italic>\u2009=\u20090.04) and the lactate values (3.8 [1.7\u20135.9] mmol\/L vs. 2.5 [1.5\u20133.4] mmol\/L;<jats:italic>p<\/jats:italic>\u2009=\u20090.01) after 6\u00a0h of support with Impella 5.0. Furthermore, at Impella removal the patients\u2019 left ventricular ejection fraction improved significantly (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) when compared to baseline. Cardiac recovery, bridge to left ventricular assist device or heart transplantation was possible in 28 patients (70\u00a0%). Twenty-six patients (65\u00a0%) survived at day 28. A multivariate analysis showed a higher risk of mortality for patients with acute myocardial infarction (hazard ratio\u2009=\u20094.1 (1.2\u201314.2);<jats:italic>p<\/jats:italic>\u2009=\u20090.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Impella 5.0 allowed fast weaning of inotropes and might facilitate myocardial recovery. Despite high severity scores at admission, day-28 mortality rate was better than predicated.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13054-015-1073-8","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T11:50:16Z","timestamp":1444391416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock"],"prefix":"10.1186","volume":"19","author":[{"given":"Philippe","family":"Gaudard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Eliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norddine","family":"Zeroual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Culas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rouvi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Albat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787\u2013847.","journal-title":"Eur Heart J"},{"key":"1073_CR2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/eurheartj\/eht248","volume":"35","author":"K Werdan","year":"2014","unstructured":"Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J. 2014;35:156\u201367.","journal-title":"Eur Heart J."},{"key":"1073_CR3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287\u201396.","journal-title":"N Engl J Med."},{"key":"1073_CR4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","volume":"382","author":"H Thiele","year":"2013","unstructured":"Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12\u00a0month results of a randomized, open-label trial. Lancet. 2013;382:1638\u201345.","journal-title":"Lancet."},{"key":"1073_CR5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/CCM.0b013e31816f7cf7","volume":"36","author":"A Combes","year":"2008","unstructured":"Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, L\u00e9ger P, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med. 2008;36:1404\u201311.","journal-title":"Crit Care Med."},{"key":"1073_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(08)60958-7","volume":"372","author":"YS Chen","year":"2008","unstructured":"Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372:554\u201361.","journal-title":"Lancet."},{"key":"1073_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/eurheartj\/ehs081","volume":"34","author":"S Beurtheret","year":"2013","unstructured":"Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, L\u00e9ger P, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J. 2013;34:112\u201320.","journal-title":"Eur Heart J."},{"key":"1073_CR8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0267659112443722","volume":"27","author":"B Soleimani","year":"2012","unstructured":"Soleimani B, Pae WE. Management of left ventricular distension during peripheral extracorporeal membrane oxygenation for cardiogenic shock. Perfusion. 2012;27:326\u201331.","journal-title":"Perfusion."},{"key":"1073_CR9","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/CCM.0000000000000410","volume":"42","author":"T Petroni","year":"2014","unstructured":"Petroni T, Harrois A, Amour J, Lebreton G, Brechot N, Tanaka S, et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Crit Care Med. 2014;42:2075\u201382.","journal-title":"Crit Care Med."},{"key":"1073_CR10","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1097\/CCM.0b013e31821e89b5","volume":"39","author":"AE Engstrom","year":"2011","unstructured":"Engstrom AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J, et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med. 2011;39:2072\u20139.","journal-title":"Crit Care Med"},{"key":"1073_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.athoracsur.2013.07.053","volume":"97","author":"A Lemaire","year":"2014","unstructured":"Lemaire A, Anderson MB, Lee LY, Scholz P, Prendergast T, Goodman A, et al. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg. 2014;97:133\u20138.","journal-title":"Ann Thorac Surg."},{"key":"1073_CR12","first-page":"539","volume":"61","author":"AE Engstrom","year":"2013","unstructured":"Engstrom AE, Granfeldt H, Seybold-Epting W, Dahm M, Cocchieri R, Driessen AH, et al. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience. Minerva Cardioangiol. 2013;61:539\u201346.","journal-title":"Minerva Cardioangiol"},{"key":"1073_CR13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jtcvs.2012.01.067","volume":"145","author":"BP Griffith","year":"2013","unstructured":"Griffith BP, Anderson MB, Samuels LE, Pae Jr WE, Naka Y, The FOH, et al. a multicenter prospective study of Impella 5.0\/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg. 2013;145:548\u201354.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1073_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jcin.2012.12.122","volume":"6","author":"X Wei","year":"2013","unstructured":"Wei X, Li T, Hagen B, Zhang P, Sanchez PG, Williams K, et al. Short-term mechanical unloading with left ventricular assist devices after acute myocardial infarction conserves calcium cycling and improves heart function. JACC Cardiovasc Interv. 2013;6:406\u201315.","journal-title":"JACC Cardiovasc Interv."},{"key":"1073_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MAT.0b013e31820e121c","volume":"57","author":"D Kawashima","year":"2011","unstructured":"Kawashima D, Gojo S, Nishimura T, Itoda Y, Kitahori K, Motomura N, et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J. 2011;57:169\u201376.","journal-title":"ASAIO J."},{"key":"1073_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00134-005-0016-2","volume":"32","author":"D Vlasselaers","year":"2006","unstructured":"Vlasselaers D, Desmet M, Desmet L, Meyns B, Dens J. Ventricular unloading with a miniature axial flow pump in combination with extracorporeal membrane oxygenation. Intensive Care Med. 2006;32:329\u201333.","journal-title":"Intensive Care Med."},{"key":"1073_CR17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MAT.0b013e31829f0e52","volume":"59","author":"A Cheng","year":"2013","unstructured":"Cheng A, Swartz MF, Massey HT. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO J. 2013;59:533\u20136.","journal-title":"ASAIO J."},{"key":"1073_CR18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1540-8191.2011.01338.x","volume":"26","author":"MS Koeckert","year":"2011","unstructured":"Koeckert MS, Jorde UP, Naka Y, Moses JW, Takayama H. Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg. 2011;26:666\u20138.","journal-title":"J Card Surg"},{"key":"1073_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MAT.0b013e31824c38ef","volume":"58","author":"S Beurtheret","year":"2012","unstructured":"Beurtheret S, Mordant P, Pavie A, Leprince P. Impella and extracorporeal membrane oxygenation: a demanding combination. ASAIO J. 2012;58:291\u20133.","journal-title":"ASAIO J."},{"key":"1073_CR20","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270:2957\u201363.","journal-title":"JAMA."},{"key":"1073_CR21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala S, De Mendonca A, Bruining H, Reinhart CK, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"1073_CR22","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/01.CIR.92.8.2226","volume":"92","author":"G Wernovsky","year":"1995","unstructured":"Wernovsky G, Wypij D, Jonas RA, Mayer Jr JE, Hanley FL, Hickey PR, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92:2226\u201335.","journal-title":"Circulation"},{"key":"1073_CR23","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00134-012-2544-x","volume":"38","author":"J Davidson","year":"2012","unstructured":"Davidson J, Tong S, Hancock H, Hauck A, da Cruz E, Kaufman J. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery. Intensive Care Med. 2012;38:1184\u201390.","journal-title":"Intensive Care Med."},{"key":"1073_CR24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224","volume":"6","author":"A Lauten","year":"2013","unstructured":"Lauten A, Engstrom AE, Jung C, Empen K, Erne P, Cook S, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013;6:23\u201330.","journal-title":"Circ Heart Fail"},{"key":"1073_CR25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jtcvs.2003.09.055","volume":"127","author":"MP Siegenthaler","year":"2004","unstructured":"Siegenthaler MP, Brehm K, Strecker T, Hanke T, N\u00f6tzold A, Olschewski M, et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg. 2004;127:812\u201322.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"1073_CR26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jtcvs.2009.10.043","volume":"139","author":"AJ Rastan","year":"2010","unstructured":"Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139:302\u201311.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"1073_CR27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/MAT.0b013e3182a8baf7","volume":"59","author":"T Chamogeorgakis","year":"2013","unstructured":"Chamogeorgakis T, Rafael A, Shafii AE, Nagpal D, Pokersnik JA, Gonzalez-Stawinski GV. Which is better: a miniaturized percutaneous ventricular assist device or extracorporeal membrane oxygenation for patients with cardiogenic shock? ASAIO J. 2013;59:607\u201311.","journal-title":"ASAIO J."},{"key":"1073_CR28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00134-011-2435-6","volume":"38","author":"CL Tacon","year":"2012","unstructured":"Tacon CL, McCaffrey J, Delaney A. Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomized controlled trials. Intensive Care Med. 2012;38:359\u201367.","journal-title":"Intensive Care Med."},{"key":"1073_CR29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/ALN.0000000000000224","volume":"120","author":"DV Nielsen","year":"2014","unstructured":"Nielsen DV, Hansen MK, Johnsen SP, Hansen M, Hindsholm K, Jakobsen CJ, et al. Health outcomes with and without use of inotropic therapy in cardiac surgery: results of a propensity score-matched analysis. Anesthesiology. 2014;120:1098\u2013108.","journal-title":"Anesthesiology."},{"key":"1073_CR30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.cir.0000032896.55215.a0","volume":"106","author":"C Stamm","year":"2002","unstructured":"Stamm C, Friehs I, Cowan DB, Cao-Danh H, Choi YH, Duebener LF, et al. Dopamine treatment of postischemic contractile dysfunction rapidly induces calcium-dependent pro-apoptotic signaling. Circulation. 2002;106:290\u20138.","journal-title":"Circulation."},{"key":"1073_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/joic.12172","volume":"28","author":"F Casassus","year":"2015","unstructured":"Casassus F, Corre J, Leroux L, Chevalereau P, Fresselinat A, Seguy B, et al. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction. J Interv Cardiol. 2015;28:41\u201350.","journal-title":"J Interv Cardiol"},{"key":"1073_CR32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.hlc.2013.10.081","volume":"23","author":"P Ma","year":"2014","unstructured":"Ma P, Zhang Z, Song T, Yang Y, Meng G, Zhao J, et al. Combining ECMO with IABP for the treatment of critically Ill adult heart failure patients. Heart Lung Circ. 2014;23:363\u20138.","journal-title":"Heart Lung Circ."},{"key":"1073_CR33","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","volume":"30","author":"JM Cheng","year":"2009","unstructured":"Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LSD, van Domburg RT, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102\u20138.","journal-title":"Eur Heart J"},{"key":"1073_CR34","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/01.CCM.0000217920.48559.D8","volume":"34","author":"CG Koch","year":"2006","unstructured":"Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608\u201316.","journal-title":"Crit Care Med."},{"key":"1073_CR35","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","volume":"116","author":"GJ Murphy","year":"2007","unstructured":"Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544\u201352.","journal-title":"Circulation."},{"key":"1073_CR36","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1111\/j.1525-1594.2011.01423.x","volume":"36","author":"A Loforte","year":"2012","unstructured":"Loforte A, Montalto A, Ranocchi F, Della Monica PL, Casali G, Lappa A, et al. Peripheral extracorporeal membrane oxygenation system as salvage treatment of patients with refractory cardiogenic shock: preliminary outcome evaluation. Artif Organs. 2012;36:E53\u201361.","journal-title":"Artif Organs."},{"key":"1073_CR37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ane.0b013e31818d8b92","volume":"108","author":"F Haddad","year":"2009","unstructured":"Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: pathophysiology, clinical importance, and management. Anesth Analg. 2009;108:422\u201333.","journal-title":"Anesth Analg."},{"key":"1073_CR38","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.amjcard.2009.11.026","volume":"105","author":"SG Drakos","year":"2010","unstructured":"Drakos SG, Janicki L, Kfoury AG, Reid BB, Clayson S, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010;105:1030\u20135.","journal-title":"Am J Cardiol."},{"key":"1073_CR39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12265-010-9216-4","volume":"3","author":"R John","year":"2010","unstructured":"John R, Lee S, Eckman P, Liao K. Right ventricular failure: a continuing problem in patients with left ventricular assist device support. J Cardiovasc Transl Res. 2010;3:604\u201311.","journal-title":"J Cardiovasc Transl Res."},{"key":"1073_CR40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.cir.0000032906.33237.1c","volume":"106","author":"Y Ochiai","year":"2002","unstructured":"Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106:198\u2013202.","journal-title":"Circulation."},{"key":"1073_CR41","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jacc.2008.03.009","volume":"51","author":"JC Matthews","year":"2008","unstructured":"Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163\u201372.","journal-title":"J Am Coll Cardiol."},{"key":"1073_CR42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jacc.2012.02.073","volume":"60","author":"AD Grant","year":"2012","unstructured":"Grant AD, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521\u20138.","journal-title":"J Am Coll Cardiol."},{"key":"1073_CR43","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/cc8114","volume":"13","author":"C Torgersen","year":"2009","unstructured":"Torgersen C, Schmittinger CA, Wagner S, Ulmer H, Takala J, Jakob SM, et al. Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study. Crit Care. 2009;13:R157.","journal-title":"Crit Care."},{"key":"1073_CR44","doi-asserted-by":"crossref","unstructured":"Samuels LE, Kaufman MS, Morris RJ. Pharmacologic criteria for ventricular assist device insertion: experience with the Abiomed BVS 5000 system. J Card Surg. 1999;288\u201393.","DOI":"10.1111\/j.1540-8191.1999.tb00996.x"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1073-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-015-1073-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1073-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1073-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T22:51:40Z","timestamp":1653259900000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-015-1073-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1186\/s13054-015-1073-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"8 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"363"}}